{"timestamp": 1771594748.7263353, "value": {"ticker": "AKTX", "company_name": "Akari Therapeutics, Plc", "short_name": "Akari Therapeutics Plc", "sector": "Healthcare", "industry": "Biotechnology", "country": "United States", "market_cap": 10804907, "float_shares": 43052079963, "shares_outstanding": 45783505, "short_ratio": 0.53, "short_percent_of_float": 0.01, "shares_short": 239584, "shares_short_prior": 433343, "insider_percent_held": 0.24572, "institution_percent_held": 0.098009996, "total_cash": 2484000, "total_debt": 2217000, "total_revenue": 0, "revenue_growth": 0, "earnings_growth": 0, "profit_margins": 0.0, "gross_margins": 0.0, "operating_margins": 0.0, "debt_to_equity": 9.772, "current_ratio": 0.189, "book_value": 0.696, "price_to_book": 0.33908048, "operating_cashflow": -9651000, "free_cashflow": 279375, "price": 0.236, "52w_high": 1.73, "52w_low": 0.218, "avg_volume": 1090620, "avg_volume_10d": 176630, "full_time_employees": 8, "audit_risk": 0, "overall_risk": 0}}